Scientists capture atomic images to improve RNA interference drug design +++ +++ ++

Scientists capture atomic images to improve RNA interference drug design https://www.news-medical.net/news/20260629/Scientists-capture-atomic-images-to-improve-RNA-interference-drug-design.aspx?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=drug_discovery_newsletter_9_july_2026 Scientists capture atomic images to improve RNA interference drug designRNA interference is a natural mechanism for living cells to control whether specific genes are being used or not. Study identifies promising drug target to prevent neurodegenerative conditions https://www.news-medical.net/news/20260706/Study-identifies-promising-drug-target-to-prevent-neurodegenerative-conditions.aspx?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=drug_discovery_newsletter_9_july_2026 Study identifies promising drug target to prevent neurodegenerative conditionsParkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease. Clinical trial evaluates generative AI support tool in primary care https://www.news-medical.net/news/20260626/Clinical-trial-evaluates-generative-AI-support-tool-in-primary-care.aspx?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=drug_discovery_newsletter_9_july_2026 Clinical trial evaluates generative AI support tool in primary careA large real-world clinical trial has found that a generative AI-powered support tool used to support frontline clinicians was safe and improved the quality of clinical decision-making but did not significantly change short-term patient outcomes. Insilico Medicine partners with Takeda for AI-driven drug discovery https://www.news-medical.net/news/20260702/Insilico-Medicine-partners-with-Takeda-for-AI-driven-drug-discovery.aspx?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=drug_discovery_newsletter_9_july_2026 Insilico Medicine partners with Takeda for AI-driven drug discoveryInsilico Medicine, a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas. WHO launches PARTNERS clinical trial for Bundibugyo virus treatments https://www.news-medical.net/news/20260703/WHO-launches-PARTNERS-clinical-trial-for-Bundibugyo-virus-treatments.aspx?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=drug_discovery_newsletter_9_july_2026 WHO launches PARTNERS clinical trial for Bundibugyo virus treatmentsIn a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the PARTNERS clinical trial has opened enrolment today for patients in the Democratic Republic of the Congo. Insilico Medicine highlights AI drug discovery progress at executive summit https://www.news-medical.net/news/20260703/Insilico-Medicine-highlights-AI-drug-discovery-progress-at-executive-summit.aspx?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=drug_discovery_newsletter_9_july_2026 Insilico Medicine highlights AI drug discovery progress at executive summitDr. Alex Aliper, Co-founder and President of Insilico Medicine, will attend the AI for Good Global Summit 2026 in Geneva, Switzerland, on July 7. New EV-SELEX strategy accelerates drug discovery for wide range of GPCRs https://www.news-medical.net/news/20260707/New-EV-SELEX-strategy-accelerates-drug-discovery-for-wide-range-of-GPCRs.aspx?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=drug_discovery_newsletter_9_july_2026 New EV-SELEX strategy accelerates drug discovery for wide range of GPCRsG protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, which regulate diverse physiological processes ranging from pain perception to hormone signaling. Collaborative AI system helps accelerate clinical trial design https://www.news-medical.net/news/20260707/Collaborative-AI-system-helps-accelerate-clinical-trial-design.aspx?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=drug_discovery_newsletter_9_july_2026 Collaborative AI system helps accelerate clinical trial designAn artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a new study by Weill Cornell Medicine investigators.